Table 2. Baseline clinical characteristics of DLBCL patients with different IRF8 expression.
Variable | IRF8 in tumor tissues | |
---|---|---|
Low (n=41) | High (n=26) | |
Age (years) | ||
<50 | 15 | 10 |
≥50 | 26 | 16 |
P value | 0.552 | |
Gender | ||
Male | 25 | 15 |
Female | 16 | 11 |
P value | 0.485 | |
Ann Arbor stagea | ||
I-II | 11 | 7 |
III-IV | 30 | 19 |
P value | 0.392 | |
IPI scoreb | ||
1-3 | 28 | 19 |
4-5 | 13 | 7 |
P value | 0.241 |
aAnn Arbor stage according to Ann Arbor-Cotswald stage (1989).
bIPI score, International Prognostic Index score.